/

Sociétés

Cu

Non vérifié

Curium

Ce que nous écrivons

Annonces ÉconomiquesIndustrie pharmaceutiqueManagement/Organisation d'EntrepriseMédecine Santé Bien-être

12 communiqués de presse

Voir tous les communiqués de presse

20/11/2025

Industrie pharmaceutique

CapVest recapitalizes Curium to accelerate its growth strategy, marking the largest transaction in nuclear medicine globally

Source

Émetteur

1.00

0

19/11/2025

Industrie pharmaceutique

Management/Organisation d'Entreprise

Médecine Santé Bien-être

Curium Announces First Commercial Doses of Diagnostic Radiopharmaceutical in Czech Republic and Slovakia for Patients with Prostate Cancer

Source

Émetteur

1.00

0

17/11/2025

Industrie pharmaceutique

Annonces Économiques

Curium Consolidates New Biopharma Business and Sets Up Global Headquarters in Boston, Massachusetts

Source

Émetteur

1.00

0

14/10/2025

Industrie pharmaceutique

Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan

Source

Émetteur

1.00

0

21/05/2025

Industrie pharmaceutique

Management/Organisation d'Entreprise

Curium and NRG PALLAS extend collaboration in the supply of essential medical isotope to hospitals

Source

Émetteur

1.00

0

12/05/2025

Industrie pharmaceutique

Médecine Santé Bien-être

Annonces Économiques

Curium receives marketing authorization in Switzerland for PYLCLARI® – an innovative 18F-PSMA PET tracer indicated in patients with prostate cancer

Source

Émetteur

1.00

0

10/04/2025

Industrie pharmaceutique

Curium strengthens its PET manufacturing capacity and expands European footprint with the acquisition of Nucleis

Source

Émetteur

1.00

0

27/03/2025

Industrie pharmaceutique

Curium Completes the Acquisition of Monrol as Part of its Plan to Significantly Expand Lutetium-177 Capacity and PET Footprint

Source

Émetteur

1.00

0

30/01/2025

Industrie pharmaceutique

Annonces Économiques

Management/Organisation d'Entreprise

Curium Expands European Supply of Iodine-131 Diagnostic Capsules with New Partnership Agreement with Izotop

Source

Émetteur

1.00

0

28/01/2025

Industrie pharmaceutique

Annonces Économiques

Curium Further Expands European Availability of PYLCLARI – an Innovative 18F-PSMA PET Radiopharmaceutical Indicated in Patients with Prostate Cancer

Source

Émetteur

1.00

0

Followers

0

Compatibilité

0